Tegoprazan- Versus PPI-based H. Pylori Eradication — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Tegoprazan- Versus PPI-based H. Pylori Eradication — Stella

Home/H.Pylori Infection/

View on ClinicalTrials.gov

Recruiting

Back to H.Pylori Infection trials

Trial locations(1 site)

South Korea

Digestive Disease Center, Soonchunhyang University Hospital, Seoul

Key details

Sponsor

Soonchunhyang University Hospital

Enrollment target

~200 participants

Started

December 2024

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

20 Years – 80 Years

Last updated April 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.